Cotreatment with a novel phosphoinositide analogue inhibitor and carmustine enhances chemotherapeutic efficacy by attenuating AKT activity in gliomas.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples